Window of Opportunity in the Treatment of Rheumatoid Arthritis-Interstitial Lung Disease with Abatacept. National Multicenter Study of 509 Patients

被引:0
|
作者
Serrano-Combarro, Ana [1 ]
Atienza-Mateo, Belen [2 ]
Ibarrola-Paino, Libe [3 ]
Casafont-Sole, Ivette [4 ]
Melero-Gonzalez, Rafael Benito [5 ]
Perez Linaza, Alba [6 ]
Castaneda, Santos [7 ]
Ortega Castro, Rafaela [8 ]
Mena Vazquez, Natalia [9 ]
Vegas Revenga, Nuria [10 ]
Dominguez Casas, Lucia Cristina [11 ]
Peralta, Cilia [12 ]
Perez-Sandoval, Trinidad [13 ]
Perez-Albadalejo, Lorena [14 ]
Lopez-Sanchez, Ruben [15 ]
Manzano Canabal, Maria Guadalupe [16 ]
Brandy-Garcia, Anahy Maria [17 ]
Lopez-Viejo, Patricia [18 ]
Bonilla, Gema [19 ]
Maiz-Alonso, Olga [20 ]
Carrasco-Cubero, Carmen [21 ]
Garijo Bufort, Marta [22 ]
Moreno, Mireia [23 ]
Urruticoechea, Ana [24 ]
Ordonez-Palau, Sergio [25 ]
Gonzalez-Montagut Gomez, Carmen [26 ]
Garcia-Valle, Andrea [27 ]
Jimenez De Aber, Juan Ramon De Dios [28 ]
Lozano, Fernando [29 ]
Vazquez-Rodriguez, Tomas [30 ]
Martin-Lopez, Maria [31 ]
Blanco-Madrigal, Juan Maria [32 ]
Fernandez-Lozano, Delia [33 ]
Brana Abascal, Ignacio [34 ]
Loarce-Martos, Jesus [35 ]
Giner-Serret, Emilio [36 ]
Ruiz-Esquide, Virginia [37 ]
Ventin-Rodriguez, Clara [38 ]
Rodriguez-lopez, Marina [39 ]
Andujar-Brazal, Pablo [40 ]
Fernandez-Melon, Julia [41 ]
Maria Lopez, Lilian [42 ]
Fernandez-Diaz, Carlos [43 ]
Loricera, Javier [44 ]
Ferraz Amaro, Ivan [45 ]
Ferrer, Diego [46 ]
Blanco, Ricardo [47 ]
机构
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Santander, Spain
[2] Hosp Univ Marques Valdecilla, Rheumatol, IDIVAL, Santander, Spain
[3] Hosp Univ Navarra, Pamplona, Spain
[4] Hosp Univ Germans Trias i Pujol, Badalona, Spain
[5] CHU Vigo, O Carballino, Spain
[6] Serv Reumatol, Cadiz, Spain
[7] Hosp Univ Princesa, Madrid, Spain
[8] Hosp Reina Sofia, Cordoba, Spain
[9] IBIMA, Malaga, Spain
[10] Hosp Galdakao Usansolo, Galdakao, Spain
[11] Hosp Univ San Agustin, Oviedo, Spain
[12] Hosp Clin Lozano Blesa, Zaragoza, Spain
[13] Hosp Leon, Leon, Spain
[14] Hosp Univ Jaen, Div Rheumatol, Jaen, Spain
[15] Hosp Univ Gran Canaria Doctor Negrin, Las Palmas Gran Canaria, Spain
[16] CAZA, Salamanca, Spain
[17] Hosp Germans Trias i Pujol, Badalona, Spain
[18] Hosp Severo Ochoa, Div Rheumatol, Leganez, Spain
[19] Hosp Clin Univ La Paz, Dept Rheumatol, Madrid, Spain
[20] Univ Hosp Donostia, San Sebastian, Spain
[21] Hosp Univ Badajoz, Dept Rheumatol, Badajoz, Spain
[22] Hosp Sagunto, Valencia, Spain
[23] Parc Tauli Hosp Univ, UAB I3PT, Barcelona, Spain
[24] Hosp Can Misses, Ibiza, Spain
[25] H Arnau de Vilanova, Lleida, Spain
[26] Hosp Clin Univ Valladolid, Valladolid, Spain
[27] Complejo Asistencial Univ Palencia, Div Rheumatol, Palencia, Spain
[28] Hosp Araba, Alava, Spain
[29] Hosp Univ 12 Octubre, Madrid, Spain
[30] Complejo Hosp Univ Ferrol, Rheumatol, La Coruna, Spain
[31] Hosp 12 Octubre, Madrid, Spain
[32] Hosp Univ Basurto, Div Rheumatol, Bilbao, Spain
[33] Hosp Merida, Merida, Spain
[34] Hosp Univ Cent Asturias, Div Rheumatol, Oviedo, Spain
[35] Ramon & Cajal Univ Hosp, Madrid, Spain
[36] Hosp Royo Villanova, Teruel, Spain
[37] Hosp Clin Barcelona, Rheumatol, Barcelona, Spain
[38] Hosp Univ A Coruna, Div Rheumatol, La Coruna, Spain
[39] Hosp Clin Univ Santiago, Div Rheumatol, La Coruna, Spain
[40] Hosp Univ Doctor Peset, Div Rheumatol, Valencia, Spain
[41] Hosp Univ Son Espases, Div Rheumatol, Palma de Mallorca, Spain
[42] Hosp Univ Son Llatzer, Div Rheumatol, Mallorca, Spain
[43] Hosp Univ Reina Sofia, Div Rheumatol, Murcia, Spain
[44] Hosp Univ Marques Valdecilla, Santander, Spain
[45] Hosp Univ Canarias, Santa Cruz de Tenerife, Spain
[46] Hosp Univ Marques Valdecilla, Div Pneumol, IDIVAL, Santander, Spain
[47] Hosp Univ Marques Valdecilla, IDIVAL, Santander, Spain
[48] Spanish Collaborat Grp Interstitial Lung Dis Asso, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2173
引用
收藏
页码:4291 / 4294
页数:4
相关论文
共 50 条
  • [31] THE SAFETY AND TREATMENT EFFICACY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH INTERSTITIAL LUNG DISEASE: FROM THE TSURUMAI BIOLOGICS COMMUNICATION REGISTRY (TBCR) MULTICENTER STUDY
    Hirabara, S.
    Kojima, T.
    Takahashi, N.
    Kaneko, A.
    Kida, D.
    Hirano, Y.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 455 - 455
  • [32] Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients
    Nakashita, Tamao
    Ando, Katsutoshi
    Takahashi, Kazuhisa
    Motojima, Shinji
    RESPIRATORY INVESTIGATION, 2016, 54 (05) : 376 - 379
  • [33] Rituximab in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicenter Study of 32 Patients
    Fernandez-Diaz, Carlos
    Reina, Delia
    Rubio-Munoz, Paula
    Urruticoechea-Arana, Ana
    Carrasco-cubero, Maria
    Martin-Lopez, Maria
    Miranda-Filloy, Jose A.
    Villa-Blanco, Ignacio
    Milena Millan, Ana
    Castellvi, Ivan
    Maiz-Alonso, Olga
    Juan, Antonio
    Alvarez Reyes, Fatima
    Luis Martin-Varillas, Jose
    Vegas-Revenga, Nuria
    Blanco, Ricardo
    Angel Gonzalez-Gay, Miguel
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [34] EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS.
    Rodriguez, R. Redondo
    Godoy-Navarrete, F.
    Morales-Garrido, P.
    Rojas-Gimenez, M.
    Romero-Barco, C. M.
    Mena-Vazquez, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 599 - 599
  • [35] Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers
    Doyle, Tracy J.
    Patel, Avignat S.
    Hatabu, Hiroto
    Nishino, Mizuki
    Wu, Guodong
    Osorio, Juan C.
    Golzarri, Maria F.
    Traslosheros, Andres
    Chu, Sarah G.
    Frits, Michelle L.
    Iannaccone, Christine K.
    Koontz, Diane
    Fuhrman, Carl
    Weinblatt, Michael E.
    El-Chemaly, Souheil Y.
    Washko, George R.
    Hunninghake, Gary M.
    Choi, Augustine M. K.
    Dellaripa, Paul F.
    Oddis, Chester V.
    Shadick, Nancy A.
    Ascherman, Dana P.
    Rosas, Ivan O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (12) : 1403 - 1412
  • [36] Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?
    Akiyama, Mitsuhiro
    Alshehri, Waleed
    Kaneko, Yuko
    AUTOIMMUNITY REVIEWS, 2024, 23 (02)
  • [37] THE POTENT WEAPON FOR RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE : RITUXIMAB EXPERIENCES
    Karakas, Burak
    Derin, Mehmet Emin
    Albayrak, Fatih
    Sahin, Ali
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1663 - 1663
  • [38] RITUXIMAB IN RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE: A MULTICENTER STUDY
    Fernandez-Diaz, C.
    Martin-Lopez, M.
    Carrasco-Cubero, M.
    Reina-Sanz, D.
    Rubio-Munoz, P.
    Urruticoechea-Arana, A.
    Miranda-Filloy, J.
    Vegas-Revenga, N.
    Dominguez-Casas, L.
    Gonzalez-Gay, M.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 569 - 570
  • [39] Validation of minimal disease activity for rheumatoid arthritis patients treated with the biologic therapy abatacept.
    Wells, George A.
    Boers, Maarten
    Li, Tracy
    Tugwell, Peter
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S384 - S385
  • [40] Comparison of the Efficacy and Safety of Abatacept in Rheumatoid Arthritis Patients with and Without Interstitial Lung Disease
    Sasaki, Sho
    Ishii, Akira
    Sugiyama, Mai
    Izumi, Yuto
    Nakagome, Yoko
    Hirano, Kazuki
    Kurabayashi, Takayoshi
    Sasaki, Noriko
    Yamada, Chiho
    Sato, Shinji
    ARTHRITIS & RHEUMATOLOGY, 2019, 71